Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
4,154
archived clinical trials in
Osteoarthritis (OA)

Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  3/27/2018
Regeneron Investigational Site
73
mi
from 91732
Carlsbad, CA
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 3/27/2018
Regeneron Investigational Site
73
mi
from 91732
Carlsbad, CA
Click here to add this to my saved trials
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  3/27/2018
Regeneron Investigational Site
105
mi
from 91732
San Diego, CA
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 3/27/2018
Regeneron Investigational Site
105
mi
from 91732
San Diego, CA
Click here to add this to my saved trials
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  3/27/2018
Regeneron Investigational Site
399
mi
from 91732
Santa Rosa, CA
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 3/27/2018
Regeneron Investigational Site
399
mi
from 91732
Santa Rosa, CA
Click here to add this to my saved trials
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  3/27/2018
Regeneron Investigational Site
74
mi
from 91732
Vista, CA
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 3/27/2018
Regeneron Investigational Site
74
mi
from 91732
Vista, CA
Click here to add this to my saved trials
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  3/27/2018
Regeneron Study Site
825
mi
from 91732
Aurora, CO
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 3/27/2018
Regeneron Study Site
825
mi
from 91732
Aurora, CO
Click here to add this to my saved trials
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  3/27/2018
Regeneron Investigational Site
802
mi
from 91732
Colorado Springs, CO
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 3/27/2018
Regeneron Investigational Site
802
mi
from 91732
Colorado Springs, CO
Click here to add this to my saved trials
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  3/27/2018
Regeneron Investigational Site
812
mi
from 91732
Lakewood, CO
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 3/27/2018
Regeneron Investigational Site
812
mi
from 91732
Lakewood, CO
Click here to add this to my saved trials
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  3/27/2018
Regeneron Investigational Site
813
mi
from 91732
Littleton, CO
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 3/27/2018
Regeneron Investigational Site
813
mi
from 91732
Littleton, CO
Click here to add this to my saved trials
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  3/27/2018
Regeneron Investigational Site
2116
mi
from 91732
Clearwater, FL
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 3/27/2018
Regeneron Investigational Site
2116
mi
from 91732
Clearwater, FL
Click here to add this to my saved trials
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  3/27/2018
Regeneron Study Site
2184
mi
from 91732
Orlando, FL
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 3/27/2018
Regeneron Study Site
2184
mi
from 91732
Orlando, FL
Click here to add this to my saved trials
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  3/27/2018
Regeneron Investigational Site
2125
mi
from 91732
Pinellas Park, FL
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 3/27/2018
Regeneron Investigational Site
2125
mi
from 91732
Pinellas Park, FL
Click here to add this to my saved trials
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  3/27/2018
Regeneron Study Site
1919
mi
from 91732
Atlanta, GA
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 3/27/2018
Regeneron Study Site
1919
mi
from 91732
Atlanta, GA
Click here to add this to my saved trials
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  3/27/2018
Regeneron Study Site
1728
mi
from 91732
Chicago, IL
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 3/27/2018
Regeneron Study Site
1728
mi
from 91732
Chicago, IL
Click here to add this to my saved trials
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  3/27/2018
Regeneron Investigational Site
1585
mi
from 91732
Evansville, IL
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 3/27/2018
Regeneron Investigational Site
1585
mi
from 91732
Evansville, IL
Click here to add this to my saved trials
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  3/27/2018
Regeneron Investigational Site
1304
mi
from 91732
Council Bluffs, IA
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 3/27/2018
Regeneron Investigational Site
1304
mi
from 91732
Council Bluffs, IA
Click here to add this to my saved trials
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  3/27/2018
Regeneron Investigational Site
2258
mi
from 91732
Frederick, MD
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 3/27/2018
Regeneron Investigational Site
2258
mi
from 91732
Frederick, MD
Click here to add this to my saved trials
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  3/27/2018
Regeneron Investigational Site
2540
mi
from 91732
Worcester, MA
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 3/27/2018
Regeneron Investigational Site
2540
mi
from 91732
Worcester, MA
Click here to add this to my saved trials
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  3/27/2018
Regeneron Investigational Site
1503
mi
from 91732
Edina, MN
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 3/27/2018
Regeneron Investigational Site
1503
mi
from 91732
Edina, MN
Click here to add this to my saved trials
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  3/27/2018
Regeneron Investigational Site
1573
mi
from 91732
Saint Louis, MO
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 3/27/2018
Regeneron Investigational Site
1573
mi
from 91732
Saint Louis, MO
Click here to add this to my saved trials
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  3/27/2018
Regeneron Investigational Site
1286
mi
from 91732
Elkhorn, NE
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 3/27/2018
Regeneron Investigational Site
1286
mi
from 91732
Elkhorn, NE
Click here to add this to my saved trials
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  3/27/2018
Regeneron Investigational Site
1276
mi
from 91732
Fremont, NE
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 3/27/2018
Regeneron Investigational Site
1276
mi
from 91732
Fremont, NE
Click here to add this to my saved trials
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  3/27/2018
Regeneron Investigational Site
218
mi
from 91732
Henderson, NV
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 3/27/2018
Regeneron Investigational Site
218
mi
from 91732
Henderson, NV
Click here to add this to my saved trials
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  3/27/2018
Regeneron Investigational Site
217
mi
from 91732
Las Vegas, NV
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 3/27/2018
Regeneron Investigational Site
217
mi
from 91732
Las Vegas, NV
Click here to add this to my saved trials
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  3/27/2018
Regeneron Investigational Site
2443
mi
from 91732
Jamaica, NY
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 3/27/2018
Regeneron Investigational Site
2443
mi
from 91732
Jamaica, NY
Click here to add this to my saved trials
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  3/27/2018
Regeneron Study Site
2432
mi
from 91732
New York, NY
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 3/27/2018
Regeneron Study Site
2432
mi
from 91732
New York, NY
Click here to add this to my saved trials
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  3/27/2018
Regeneron Investigational Site
2141
mi
from 91732
High Point, NC
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 3/27/2018
Regeneron Investigational Site
2141
mi
from 91732
High Point, NC
Click here to add this to my saved trials
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  3/27/2018
Regeneron Study Site
2218
mi
from 91732
Raleigh, NC
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 3/27/2018
Regeneron Study Site
2218
mi
from 91732
Raleigh, NC
Click here to add this to my saved trials
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  3/27/2018
Regeneron Investigational Site
2040
mi
from 91732
Akron, OH
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 3/27/2018
Regeneron Investigational Site
2040
mi
from 91732
Akron, OH
Click here to add this to my saved trials
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  3/27/2018
Regeneron Study Site
1882
mi
from 91732
Cincinnati, OH
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 3/27/2018
Regeneron Study Site
1882
mi
from 91732
Cincinnati, OH
Click here to add this to my saved trials
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  3/27/2018
Regeneron Study Site
1960
mi
from 91732
Columbus, OH
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 3/27/2018
Regeneron Study Site
1960
mi
from 91732
Columbus, OH
Click here to add this to my saved trials
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  3/27/2018
Regeneron Study Site
1165
mi
from 91732
Oklahoma City, OK
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 3/27/2018
Regeneron Study Site
1165
mi
from 91732
Oklahoma City, OK
Click here to add this to my saved trials
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  3/27/2018
Regeneron Investigational Site
2201
mi
from 91732
Duncansville, PA
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 3/27/2018
Regeneron Investigational Site
2201
mi
from 91732
Duncansville, PA
Click here to add this to my saved trials
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  3/27/2018
Regeneron Investigational Site
2008
mi
from 91732
Anderson, SC
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 3/27/2018
Regeneron Investigational Site
2008
mi
from 91732
Anderson, SC
Click here to add this to my saved trials
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  3/27/2018
Regeneron Investigational Site
2027
mi
from 91732
Greer, SC
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 3/27/2018
Regeneron Investigational Site
2027
mi
from 91732
Greer, SC
Click here to add this to my saved trials
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  3/27/2018
Regeneron Investigational Site
1223
mi
from 91732
Dallas, TX
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 3/27/2018
Regeneron Investigational Site
1223
mi
from 91732
Dallas, TX
Click here to add this to my saved trials
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  3/27/2018
Regeneron Study Site
1357
mi
from 91732
Houston, TX
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 3/27/2018
Regeneron Study Site
1357
mi
from 91732
Houston, TX
Click here to add this to my saved trials
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  3/27/2018
Regeneron Investigational Site
927
mi
from 91732
Lubbock, TX
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 3/27/2018
Regeneron Investigational Site
927
mi
from 91732
Lubbock, TX
Click here to add this to my saved trials
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  3/27/2018
Regeneron Investigational Site
1227
mi
from 91732
Plano, TX
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 3/27/2018
Regeneron Investigational Site
1227
mi
from 91732
Plano, TX
Click here to add this to my saved trials
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  3/27/2018
Regeneron Study Site
1188
mi
from 91732
San Antonio, TX
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 3/27/2018
Regeneron Study Site
1188
mi
from 91732
San Antonio, TX
Click here to add this to my saved trials
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  3/27/2018
Regeneron Investigational Site
6712
mi
from 91732
Burgas,
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 3/27/2018
Regeneron Investigational Site
6712
mi
from 91732
Burgas,
Click here to add this to my saved trials
A Controlled Surveillance of the Osteoarthritic Knee Microenvironment With Regenexx® SD Treatment
A Controlled Surveillance of the Osteoarthritic Knee Microenvironment With Regenexx® SD Treatment
Status: Enrolling
Updated:  3/28/2018
Centeno-Schultz Clinic
816
mi
from 91732
Broomfield, CO
A Controlled Surveillance of the Osteoarthritic Knee Microenvironment With Regenexx® SD Treatment
A Controlled Surveillance of the Osteoarthritic Knee Microenvironment With Regenexx® SD Treatment
Status: Enrolling
Updated: 3/28/2018
Centeno-Schultz Clinic
816
mi
from 91732
Broomfield, CO
Click here to add this to my saved trials
Catabolic Marker Levels After Platelet Poor Plasma (PPP) Lavage
Assessing Catabolic Marker Levels in the Knee Synovial Fluid Microenvironment After Lavage With Platelet Poor Plasma (PPP)
Status: Enrolling
Updated:  3/28/2018
Centeno-Schultz Clinic
816
mi
from 91732
Broomfield, CO
Catabolic Marker Levels After Platelet Poor Plasma (PPP) Lavage
Assessing Catabolic Marker Levels in the Knee Synovial Fluid Microenvironment After Lavage With Platelet Poor Plasma (PPP)
Status: Enrolling
Updated: 3/28/2018
Centeno-Schultz Clinic
816
mi
from 91732
Broomfield, CO
Click here to add this to my saved trials
Early Postoperative Compex Rehab NMES Use for Total Knee Arthroplasty Patients
A 12-Month Prospective, Post-Market Study of Early Postoperative Compex® Rehab NMES Use in Total Knee Arthroplasty Patients
Status: Enrolling
Updated:  4/3/2018
OrthoIndy
1795
mi
from 91732
Greenwood, IN
Early Postoperative Compex Rehab NMES Use for Total Knee Arthroplasty Patients
A 12-Month Prospective, Post-Market Study of Early Postoperative Compex® Rehab NMES Use in Total Knee Arthroplasty Patients
Status: Enrolling
Updated: 4/3/2018
OrthoIndy
1795
mi
from 91732
Greenwood, IN
Click here to add this to my saved trials
Energy Dispersive Bracing for Conservative Treatment of Knee Osteoarthritis
Status: Enrolling
Updated:  4/3/2018
OrthoIndy
1795
mi
from 91732
Greenwood, IN
Energy Dispersive Bracing for Conservative Treatment of Knee Osteoarthritis
Status: Enrolling
Updated: 4/3/2018
OrthoIndy
1795
mi
from 91732
Greenwood, IN
Click here to add this to my saved trials
The Strong Brain Study
A Pilot Study to Evaluate the Role of Brain Integrity on Post-hospital Sarcopenia
Status: Enrolling
Updated:  4/4/2018
Institute on Aging
2105
mi
from 91732
Gainesville, FL
The Strong Brain Study
A Pilot Study to Evaluate the Role of Brain Integrity on Post-hospital Sarcopenia
Status: Enrolling
Updated: 4/4/2018
Institute on Aging
2105
mi
from 91732
Gainesville, FL
Click here to add this to my saved trials
A Prospective Observational Study to Evaluate Long-term Changes in Cartilage Morphology in Subjects Who Previously Received TPX-100 or Placebo in Study TPX-100-1 for Patellar Osteoarthritis Involving Both Knees
A Prospective Observational Study to Evaluate Long-term Changes in Cartilage Morphology in Subjects Who Previously Received TPX-100 or Placebo in Study TPX-100-1 for Patellar Osteoarthritis Involving Both Knees
Status: Enrolling
Updated:  4/4/2018
Dr. Samy Metyas
6
mi
from 91732
Covina, CA
A Prospective Observational Study to Evaluate Long-term Changes in Cartilage Morphology in Subjects Who Previously Received TPX-100 or Placebo in Study TPX-100-1 for Patellar Osteoarthritis Involving Both Knees
A Prospective Observational Study to Evaluate Long-term Changes in Cartilage Morphology in Subjects Who Previously Received TPX-100 or Placebo in Study TPX-100-1 for Patellar Osteoarthritis Involving Both Knees
Status: Enrolling
Updated: 4/4/2018
Dr. Samy Metyas
6
mi
from 91732
Covina, CA
Click here to add this to my saved trials
Study of Subtalar Arthrodesis Using AlloStem® Versus Autologous Bone Graft
Study of Subtalar Arthrodesis Using AlloStem® Versus Autologous Bone Graft
Status: Enrolling
Updated:  4/11/2018
Campbell Clinic
1600
mi
from 91732
Germantown, TN
Study of Subtalar Arthrodesis Using AlloStem® Versus Autologous Bone Graft
Study of Subtalar Arthrodesis Using AlloStem® Versus Autologous Bone Graft
Status: Enrolling
Updated: 4/11/2018
Campbell Clinic
1600
mi
from 91732
Germantown, TN
Click here to add this to my saved trials
Study of Subtalar Arthrodesis Using AlloStem® Versus Autologous Bone Graft
Study of Subtalar Arthrodesis Using AlloStem® Versus Autologous Bone Graft
Status: Enrolling
Updated:  4/11/2018
Institute for Foot and Ankle Reconstruction at Mercy
2302
mi
from 91732
Baltimore, MD
Study of Subtalar Arthrodesis Using AlloStem® Versus Autologous Bone Graft
Study of Subtalar Arthrodesis Using AlloStem® Versus Autologous Bone Graft
Status: Enrolling
Updated: 4/11/2018
Institute for Foot and Ankle Reconstruction at Mercy
2302
mi
from 91732
Baltimore, MD
Click here to add this to my saved trials
Study of Subtalar Arthrodesis Using AlloStem® Versus Autologous Bone Graft
Study of Subtalar Arthrodesis Using AlloStem® Versus Autologous Bone Graft
Status: Enrolling
Updated:  4/11/2018
Minnesota Orthopedic Sports Medicine Institute (MOSMI)
1504
mi
from 91732
Edina, MN
Study of Subtalar Arthrodesis Using AlloStem® Versus Autologous Bone Graft
Study of Subtalar Arthrodesis Using AlloStem® Versus Autologous Bone Graft
Status: Enrolling
Updated: 4/11/2018
Minnesota Orthopedic Sports Medicine Institute (MOSMI)
1504
mi
from 91732
Edina, MN
Click here to add this to my saved trials
Study of Subtalar Arthrodesis Using AlloStem® Versus Autologous Bone Graft
Study of Subtalar Arthrodesis Using AlloStem® Versus Autologous Bone Graft
Status: Enrolling
Updated:  4/11/2018
Orthopaedic Associates of Michigan
1843
mi
from 91732
Grand Rapids, MI
Study of Subtalar Arthrodesis Using AlloStem® Versus Autologous Bone Graft
Study of Subtalar Arthrodesis Using AlloStem® Versus Autologous Bone Graft
Status: Enrolling
Updated: 4/11/2018
Orthopaedic Associates of Michigan
1843
mi
from 91732
Grand Rapids, MI
Click here to add this to my saved trials